123 related articles for article (PubMed ID: 9385444)
1. Differential inhibition of aflatoxin B1 oxidation by gestodene action on human liver microsomes.
Kim BR; Oh HS; Kim DH
Biochem Mol Biol Int; 1997 Nov; 43(4):839-46. PubMed ID: 9385444
[TBL] [Abstract][Full Text] [Related]
2. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
3. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
[TBL] [Abstract][Full Text] [Related]
4. Structure-function relationships of human liver cytochromes P450 3A: aflatoxin B1 metabolism as a probe.
Wang H; Dick R; Yin H; Licad-Coles E; Kroetz DL; Szklarz G; Harlow G; Halpert JR; Correia MA
Biochemistry; 1998 Sep; 37(36):12536-45. PubMed ID: 9730826
[TBL] [Abstract][Full Text] [Related]
5. Influence of P450 3A4 SRS-2 residues on cooperativity and/or regioselectivity of aflatoxin B(1) oxidation.
Xue L; Wang HF; Wang Q; Szklarz GD; Domanski TL; Halpert JR; Correia MA
Chem Res Toxicol; 2001 May; 14(5):483-91. PubMed ID: 11368545
[TBL] [Abstract][Full Text] [Related]
6. Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes.
Ueng YF; Shimada T; Yamazaki H; Guengerich FP
Chem Res Toxicol; 1995 Mar; 8(2):218-25. PubMed ID: 7766804
[TBL] [Abstract][Full Text] [Related]
7. Cooperativity in oxidations catalyzed by cytochrome P450 3A4.
Ueng YF; Kuwabara T; Chun YJ; Guengerich FP
Biochemistry; 1997 Jan; 36(2):370-81. PubMed ID: 9003190
[TBL] [Abstract][Full Text] [Related]
8. Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes.
Berthou F; Dreano Y; Belloc C; Kangas L; Gautier JC; Beaune P
Biochem Pharmacol; 1994 May; 47(10):1883-95. PubMed ID: 8204106
[TBL] [Abstract][Full Text] [Related]
9. Bioactivation of aflatoxin B1 by human liver microsomes: role of cytochrome P450 IIIA enzymes.
Ramsdell HS; Parkinson A; Eddy AC; Eaton DL
Toxicol Appl Pharmacol; 1991 May; 108(3):436-47. PubMed ID: 1902334
[TBL] [Abstract][Full Text] [Related]
10. Modulation of aflatoxin B1 biotransformation in rabbit pulmonary and hepatic microsomes.
Daniels JM; Massey TE
Toxicology; 1992 Aug; 74(1):19-32. PubMed ID: 1514185
[TBL] [Abstract][Full Text] [Related]
11. Interaction of aflatoxin B1 with cytochrome P450 2A5 and its mutants: correlation with metabolic activation and toxicity.
Pelkonen P; Lang MA; Negishi M; Wild CP; Juvonen RO
Chem Res Toxicol; 1997 Jan; 10(1):85-90. PubMed ID: 9074807
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of in vitro aflatoxin B1-DNA binding in rainbow trout by CYP1A inhibitors: alpha-naphthoflavone, beta-naphthoflavone and trout CYP1A1 peptide antibody.
Takahashi N; Miranda CL; Henderson MC; Buhler DR; Williams DE; Bailey GS
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Mar; 110(3):273-80. PubMed ID: 7599976
[TBL] [Abstract][Full Text] [Related]
13. Mixed inhibition of P450 3A4 as a chemoprotective mechanism against aflatoxin B1-induced cytotoxicity with cis-terpenones.
Zhou Q; Zhang L; Zuniga MA; Tombes RM; Stewart JK
Chem Res Toxicol; 2008 Mar; 21(3):732-8. PubMed ID: 18254608
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
15. In vitro metabolism of quinidine: the (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes.
Nielsen TL; Rasmussen BB; Flinois JP; Beaune P; Brosen K
J Pharmacol Exp Ther; 1999 Apr; 289(1):31-7. PubMed ID: 10086984
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation.
Yun CH; Okerholm RA; Guengerich FP
Drug Metab Dispos; 1993; 21(3):403-9. PubMed ID: 8100494
[TBL] [Abstract][Full Text] [Related]
17. Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes.
Kerlan V; Dreano Y; Bercovici JP; Beaune PH; Floch HH; Berthou F
Biochem Pharmacol; 1992 Nov; 44(9):1745-56. PubMed ID: 1449532
[TBL] [Abstract][Full Text] [Related]
18. Effect of an extract of the root of Scutellaria baicalensis and its flavonoids on aflatoxin B1 oxidizing cytochrome P450 enzymes.
Kim BR; Kim DH; Park R; Kwon KB; Ryu DG; Kim YC; Kim NY; Jeong S; Kang BK; Kim KS
Planta Med; 2001 Jul; 67(5):396-9. PubMed ID: 11488450
[TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism of aflatoxin B1 by normal and tumorous liver tissue from Thailand.
Kirby GM; Wolf CR; Neal GE; Judah DJ; Henderson CJ; Srivatanakul P; Wild CP
Carcinogenesis; 1993 Dec; 14(12):2613-20. PubMed ID: 8269634
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene.
Guengerich FP
Chem Res Toxicol; 1990; 3(4):363-71. PubMed ID: 2133086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]